Category: Asthma Clinical Trials U.S.

Posted on

Two Doses of the Intravenous Magnesium Sulfate Versus the Standard Single Dose ,With/ Without the Nebulized Budesonide For the Management of the Severe Asthma Exacerbation in the Emergency Room; A Randomized Controlled Trial.

Condition:   Bronchial Asthma
Interventions:   Drug: Intravenous magnesium sulfate;   Drug: Inhaled budesonide;   Drug: normal saline
Sponsor:   Hamad Medical Corporation
Recruiting – verified May 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Posted on

A Study to Compare the Efficacy of Fluticasone Furoate/Vilanterol Inhalation Powder With Usual Inhaled Corticosteroids (ICS)/Long Acting Beta Agonists (LABA) in Persistent Asthma

Condition:   Asthma
Interventions:   Drug: Fluticasone Furoate;   Drug: Vilanterol;   Drug: Fluticasone propionate;   Drug: Salmeterol;   Drug: Budesonide;   Drug: Formoterol Fumarate
Sponsor:   GlaxoSmithKline
Not yet recruiting – verified May 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Posted on

Preventing Atopic Dermatitis and ALLergies in Children

Conditions:   Asthma;   Allergy;   Rhinitis;   Child;   Atopic Dermatitis;   Obesity;   Cardiovascular Disease;   Diabetes
Interventions:   Other: Food intervention;   Other: Skin care
Sponsors:   Oslo University Hospital;   University of Oslo;   Karolinska Institutet;   Helsinki University Central Hospital;   University of Lausanne Hospitals;   Norwegian Institute of Public Health;   University Hospital, Akershus;   Ostfold Hospital Trust;   ThermoFisher Scientific Brahms Biomarkers France
Recruiting – verified May 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Posted on

Study to Determine the Pharmacokinetics and Tolerability of Fluticasone Propionate MDPI and Fluticasone Propionate/Salmeterol MDPI Compared to High Strength FLOVENT® DISKUS® and ADVAIR® DISKUS® in Patients With Persistent Asthma 12 Years of Age and Older

Condition:   Asthma
Interventions:   Drug: Treatment A: Fp MDPI;   Drug: Treatment B: FS MDPI;   Drug: Treatment C Flovent;   Drug: Treatment D:  Advair
Sponsor:   Teva Branded Pharmaceutical Products, R&D Inc.
Not yet recruiting – verified May 2015

View full post on ClinicalTrials.gov: asthma | received in the last 14 days